title: Catastrophic antiphospholipid syndrome.
authors.forename: Esmaeil M
authors.initials: EM
authors.lastname: Arbabi
authors.forename: Zia I
authors.initials: ZI
authors.lastname: Carrim
authors.forename: Mark D
authors.initials: MD
authors.lastname: Doherty
authors.forename: Colin J
authors.initials: CJ
authors.lastname: Vize
mesh_terms: D000328:Adult; D017152:Antibodies, Antiphospholipid / Q000097:blood; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000175:diagnosis* / Q000188:drug therapy; D002388:Catastrophic Illness; D059345:Cerebral Small Vessel Diseases / Q000175:diagnosis* / Q000188:drug therapy; D003229:Conjunctival Diseases / Q000175:diagnosis* / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005094:Exophthalmos / Q000175:diagnosis / Q000188:drug therapy; D005141:Eyelid Diseases / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D009916:Orbital Diseases / Q000175:diagnosis* / Q000188:drug therapy; D012082:Renal Veins / Q000473:pathology*; D014057:Tomography, X-Ray Computed; D020246:Venous Thrombosis / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D005938:Glucocorticoids; D003520:Cyclophosphamide